An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats is a research paper published in Viruses (2022). On theSindex it has a DataRank of 0. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
EveryCat Health Foundation
Grant: W21-007
University of California Center for Companion Animal Health
Grant: 2020-89-FM
NIH/NIAID
Grant: R21AI159246-01
National Institutes of Health
Grant: 5K01OD026526
NIAID NIH HHS
Grant: R21 AI159246
NIH HHS
Grant: K01 OD026526
National Institutes of Health
Grant: 1R21AI159246-01
GS-441524 is Pharmacodynamically Equivalent to Remdesivir and Pharmacokinetically Superior Drug for the Treatment of COVID-19
National Institutes of Health
Grant: 5K01OD026526-05
Defining the role of core binding factor protein interactions in osteosarcoma
University of California
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals